Picture of Star Combo Pharma logo

S66 — Star Combo Pharma News Story

0.000.00%
au flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapContrarian

Australia's Star Combo Pharma rises; posts strong Q2 group revenue

** Shares of nutritional product provider  S66.AX  rise as
much as 1.7% to A$0.3 – biggest intraday pct gain since Jan. 14
    ** Stock hits its highest level since Jan 21
    ** Co says its group revenue for Q2 FY21 up by 6% to A$7.5
mln ($5.73 mln) from same period last year  urn:newsml:reuters.com:*:nASN000RZ4
    ** Star Combo Pharma says its Q2 FY21 records positive cash
flow from operating activities of A$500,000, an improvement from
negative cash flow of A$100,000 in Q1 FY21    
    ** As of last close, S66 down 10.6% this year 
($1 = 1.3082 Australian dollars)

 (Reporting by Aditya Munjuluru in Bengaluru)
 ((aditya.srivastsav@thomsonreuters.com))

Recent news on Star Combo Pharma

See all news